Skip to main content

Adjuvant Grade II or III Meningioma JZP3507-202

Status: Coming Soon

Study Details

View study details on clinicaltrials.gov.

Locations

  • San Francisco
  • San Mateo
  • Vallejo
  • Palo Alto

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

A Phase 2 Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP3507 (ONC206) in Adults With Recurrent Grade 2 or 3 Meningioma

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?